CAPPELLI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.176
EU - Europa 4.508
AS - Asia 1.315
AF - Africa 20
SA - Sud America 13
OC - Oceania 3
Totale 12.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.161
RU - Federazione Russa 2.289
PL - Polonia 581
IT - Italia 495
IE - Irlanda 467
SG - Singapore 429
HK - Hong Kong 351
SE - Svezia 308
CN - Cina 284
IN - India 113
FI - Finlandia 101
DE - Germania 80
JO - Giordania 78
GB - Regno Unito 59
VN - Vietnam 26
CH - Svizzera 22
UA - Ucraina 22
ES - Italia 18
BE - Belgio 14
CA - Canada 14
NL - Olanda 13
CI - Costa d'Avorio 12
FR - Francia 11
JP - Giappone 9
KR - Corea 9
DK - Danimarca 8
TR - Turchia 8
RS - Serbia 5
BR - Brasile 4
KE - Kenya 4
MY - Malesia 4
AT - Austria 3
AU - Australia 3
CO - Colombia 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
AR - Argentina 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
GR - Grecia 2
MU - Mauritius 2
SC - Seychelles 2
BY - Bielorussia 1
CL - Cile 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 12.035
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.597
Warsaw 581
Fairfield 488
Dublin 465
Singapore 371
Ashburn 310
Hong Kong 254
Chandler 252
Woodbridge 199
Seattle 181
Houston 178
Cambridge 160
Wilmington 145
Moscow 124
Lawrence 103
Altamura 100
Ann Arbor 93
Florence 86
Princeton 74
Beijing 73
Mumbai 68
Shanghai 63
Helsinki 59
New York 58
Buffalo 52
San Diego 47
Medford 42
Boston 41
West Jordan 36
Kent 30
Milan 27
Rome 27
Los Angeles 25
Yubileyny 25
Dong Ket 24
Pune 24
Boardman 22
Jacksonville 22
Naples 22
Guangzhou 21
Bern 20
Lappeenranta 19
London 18
Hillsboro 16
Prato 15
Brussels 13
Falls Church 13
Munich 13
Redwood City 13
Abidjan 12
Barcelona 10
Zhengzhou 10
Norwalk 9
Chennai 8
Copenhagen 8
Seoul 8
Toronto 8
Washington 8
Falkenstein 7
Frankfurt am Main 7
Izmir 7
Phoenix 7
Pisa 7
Bologna 6
Delray Beach 6
Wuhan 6
Belgrade 5
Carmignano 5
Changsha 5
Kilburn 5
New Delhi 5
Romola 5
Shenzhen 5
Cagliari 4
Ciudad Rodrigo 4
Kuala Lumpur 4
Lecce 4
Livorno 4
Massa 4
Montreal 4
Nagold 4
Nairobi 4
Redmond 4
Siena 4
São Paulo 4
Camporeale 3
Fort Worth 3
Garmisch-Partenkirchen 3
Genoa 3
Hounslow 3
Morgantown 3
Noci 3
Nuremberg 3
Old Bridge 3
Ortezzano 3
Paris 3
Springfield 3
Wandsworth 3
Andover 2
Anghiari 2
Totale 7.969
Salva come PNG Salva come JPEG
Nome #
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: An Italian perspective 223
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon 217
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy 197
Heart failure with mid-range ejection fraction: Current evidence and uncertainties 170
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis. 162
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis 157
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 156
Different NT-proBNP circulating levels for different types of cardiac amyloidosis 156
Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria 143
Cerebral Fat Embolism After Video-Assisted Thoracic Surgery 141
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 140
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 139
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 134
Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. 134
Troponins in cardiac amyloidosis: multipurpose markers. 131
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience 124
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy 121
Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging 119
Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: The role of life satisfaction. 117
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 116
Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates 116
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 116
Anxiety and depression among AL amyloidosis patients: The role of cardiac symptoms 115
Cardiac amyloidosis: the heart of the matter. 115
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study 113
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients 110
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 108
Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis 105
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 104
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis 103
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 101
ECG abnormalities, atrial fibrillation and AV blocks in ATTR VS AL amyloidosis: an electrophysiological natural history 100
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant 100
Atrial standstill disease progression documented after 13 years follow-up 100
A Man in His 80s with Hypertension, Left Ventricular Hypertrophy, and Enlarged Biceps 97
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty 96
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 95
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 95
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis 95
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis. 92
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 92
Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it 91
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 90
Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation. 90
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 88
Cardiac amyloidosis: the heart of the matter. 87
Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. 87
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 87
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 86
Chest pain and mild left ventricular hypertrophy: a challenging diagnosis 86
Rotational mechanics of the left ventricle in AL amyloidosis. 82
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience 82
Prognostic value of fragmented QRS in cardiac AL amyloidosis 80
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 80
Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. 79
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 78
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 78
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 76
Right ventricular function in AL amyloidosis: characteristics and prognostic implication. 76
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 75
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis 74
[Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit] 73
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 72
Rotational mechanics of the left ventricle in amyloid light chain amyloidosis 71
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 71
Clinical pathway for cardiomyopathies: A genetic testing strategy proposed by ANMCO in Tuscany 69
Asymptomatic homozygous gene carrier in a family with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany? 69
Medical error and systems of signalling: conceptual and linguistic definition 69
Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy 69
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 69
Temporal Variation in Optimal Atrioventricular and Interventricular Delay During Cardiac Resynchronization Therapy 68
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 68
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 66
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 66
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus 66
A multidisciplinary case of multiple myeloma with cardiac and renal involvement: a look beyond amyloidosis 66
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 65
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 65
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry 65
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 65
Characterization of Löeffler eosinophilic myocarditis by means of real time three-dimensional contrast-enhanced echocardiography 64
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 63
Three-dimensional transesophageal evaluation of prosthetic perivalvular leak 63
Multicentre multi-device hybrid imaging study of coronary artery disease: Results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population 63
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 63
Rotational mechanics of the left ventricle in AL amyloidosis 63
Stage-specific therapy for hypertrophic cardiomyopathy 63
Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? 62
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 62
Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis 62
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 62
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 62
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 61
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 60
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 60
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 60
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 60
Concordant Versus Discordant Left Bundle Branch Block in Heart Failure Patients: Novel Clinical Value of an Old Electrocardiographic Diagnosis 60
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 60
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy 60
Totale 9.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.638
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020648 0 0 0 0 0 119 114 123 114 80 75 23
2020/2021796 41 59 32 130 74 75 36 60 85 113 49 42
2021/2022567 16 27 20 20 18 39 15 34 44 97 80 157
2022/20231.796 99 319 88 77 124 319 337 103 186 31 72 41
2023/20241.381 24 116 135 59 112 171 61 334 39 136 102 92
2024/20256.149 292 879 475 1.372 2.236 895 0 0 0 0 0 0
Totale 12.252